American Oncology Network Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +1.0% | +1.1% | +3.7% | +6.8% | -3.6% | +12.4% | +19.1% | +8.4% | +4.4% | – | |
| – | – | – | +2.2% | +1.8% | +4.6% | +6.7% | +1.5% | +12.5% | +14.0% | +7.2% | +3.4% | – | |
| – | – | – | -9.6% | -6.1% | -6.5% | +7.8% | -66.1% | +8.9% | +213.0% | +24.3% | +16.4% | – | |
| – | – | – | +1.3% | -0.1% | +0.8% | +5.4% | +10.7% | +1.4% | +29.9% | -5.4% | -1.6% | – | |
| – | +12.2% | +8,242.6% | +1.3% | +8.2% | +6.0% | +82.9% | -41.3% | -2.1% | +30.6% | -6.6% | -1.8% | – | |
| – | – | – | -46.5% | -131.1% | – | – | – | – | – | – | +413.2% | – | |
| – | – | – | +49.7% | +2.5% | +9.5% | -1.2% | +25.1% | -8.0% | +4.0% | +2.2% | -15.3% | – | |
| – | -46.6% | +198.4% | -57.4% | -157.9% | – | – | – | – | – | – | – | – | |
| – | – | +1,966.2% | +184.0% | -55.9% | -92.2% | +796.1% | -78.1% | +4,094.2% | -111.2% | – | – | – | |
| – | -47.1% | +82.9% | -24.0% | -93.1% | -1,054.2% | – | – | – | – | -129.5% | – | – | |
| – | -99.9% | +76.3% | -5.3% | -33.8% | -195.2% | – | – | – | – | +52.7% | +91.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 19, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.